Primary Care Physician Use of Counterpart Assistant Associated with 18%–22% Fewer Flu-Related Acute Care Events Among COPD and CHF Patients
Clover Health Investments, Corp. - Class A Common stock (CLOV)
Company Research
Source: GlobeNewswire
SAN FRANCISCO, March 19, 2026 (GLOBE NEWSWIRE) -- Counterpart Health,?Inc. (“Counterpart”), a wholly owned subsidiary of Clover Health Investments, Corp. (Nasdaq:?CLOV) (“Clover,” “Clover?Health” or the “Company”), and a leading AI-powered physician-enablement platform today released a whitepaper titled “Driving Clinical Excellence in Chronic Disease: Counterpart Assistant’s Role in Flu Preventative Care.” The analysis examines the role of CA’s real-time clinical insights on immunization rates and flu-related acute care utilization within Clover Health’s Medicare Advantage (MA) population. Influenza remains a major cause of morbidity among Medicare beneficiaries, with 90% to 95% of flu-related hospitalizations occurring in adults with underlying chronic conditions. For vulnerable populations, a single respiratory infection can lead to permanent functional decline. By fusing dozens of health-data streams with up-to-date clinical guidelines, CA delivers real-time recommendations that
Show less
Read more
Impact Snapshot
Event Time:
CLOV
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
CLOV alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
CLOV alerts
High impacting Clover Health Investments, Corp. - Class A Common stock news events
Weekly update
A roundup of the hottest topics
CLOV
News
- Clover Health Investments (CLOV) had its price target lowered by Canaccord Genuity Group Inc. from $3.70 to $3.20. They now have a "buy" rating on the stock.MarketBeat
- Clover Health Investments Touts AI Medicare Advantage Model, Targets GAAP Profitability in 2026 at Leerink Conference [Yahoo! Finance]Yahoo! Finance
- UPDATED – Moving from Pledge to Production, Clover Health is Now Live on Kno2, Participating in Recently Announced Federal Interoperability Initiatives [Yahoo! Finance]Yahoo! Finance
- UPDATED – Moving from Pledge to Production, Clover Health is Now Live on Kno2, Participating in Recently Announced Federal Interoperability InitiativesGlobeNewswire
- Clover Health (CLOV) Valuation Check After TEFCA Milestone And Profitability Guidance [Yahoo! Finance]Yahoo! Finance
CLOV
Earnings
- 2/26/26 - Beat
CLOV
Sec Filings
- 3/18/26 - Form 4
- 3/18/26 - Form 144
- 3/17/26 - Form 4
- CLOV's page on the SEC website